Marine sulfated glycans with serpin-unrelated anticoagulant properties
- PMID: 24772670
- DOI: 10.1016/b978-0-12-800096-0.00007-x
Marine sulfated glycans with serpin-unrelated anticoagulant properties
Abstract
Marine organisms are a rich source of sulfated polysaccharides with unique structures. Fucosylated chondroitin sulfate (FucCS) from the sea cucumber Ludwigothurea grisea and sulfated galactan from the red alga Botryocladia occidentalis are one of these unusual molecules. Besides their uncommon structures, they also exhibit high anticoagulant and antithrombotic effects. Earlier, it was considered that the anticoagulant activities of these two marine glycans were driven mainly by a catalytic serpin-dependent mechanism likewise the mammalian heparins. Its serpin-dependent anticoagulant action relies on promoting thrombin and/or factor Xa inhibition by their specific natural inhibitors (the serpins antithrombin and heparin cofactor II). However, as opposed to heparins, these two previously mentioned marine glycans were proved still capable in promoting coagulation inhibition using serpin-free plasmas. This puzzle observation was further investigated and clearly demonstrated that the cucumber FucCS and the red algal sulfated galactan have an unusual serpin-independent anticoagulant effect by inhibiting the formation of factor Xa and/or thrombin through the procoagulants tenase and prothrombinase complexes, respectively. These marine polysaccharides with unusual anticoagulant effects open clearly new perspectives for the development of new antithrombotic drugs as well as push the glycomics project.
Similar articles
-
Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.Thromb Haemost. 2008 Sep;100(3):420-8. Thromb Haemost. 2008. PMID: 18766257
-
Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.Thromb Haemost. 2009 Nov;102(5):829-36. doi: 10.1160/TH08-11-0773. Thromb Haemost. 2009. PMID: 19888516
-
Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.Thromb Haemost. 2009 Dec;102(6):1183-93. doi: 10.1160/TH09-04-0273. Thromb Haemost. 2009. PMID: 19967150 Free PMC article.
-
Use of sulfated fucans as anticoagulant and antithrombotic agents: future perspectives.Curr Pharm Des. 2004;10(9):967-81. doi: 10.2174/1381612043452730. Curr Pharm Des. 2004. PMID: 15078127 Review.
-
Sea, carbohydrates and clotting: a triad on the road of drug discovery.Mini Rev Med Chem. 2014;14(9):717-24. doi: 10.2174/1389557514666140820121048. Mini Rev Med Chem. 2014. PMID: 25138087 Review.
Cited by
-
Galactosaminoglycans: Medical Applications and Drawbacks.Molecules. 2019 Aug 1;24(15):2803. doi: 10.3390/molecules24152803. Molecules. 2019. PMID: 31374852 Free PMC article. Review.
-
Direct antitumoral effects of sulfated fucans isolated from echinoderms: a possible role of neuropilin-1/β1 integrin endocytosis and focal adhesion kinase degradation.Glycobiology. 2023 Oct 29;33(9):715-731. doi: 10.1093/glycob/cwad044. Glycobiology. 2023. PMID: 37289485 Free PMC article.
-
Structure, anti-SARS-CoV-2, and anticoagulant effects of two sulfated galactans from the red alga Botryocladia occidentalis.Int J Biol Macromol. 2023 May 31;238:124168. doi: 10.1016/j.ijbiomac.2023.124168. Epub 2023 Mar 22. Int J Biol Macromol. 2023. PMID: 36963552 Free PMC article.
-
Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium.Sci Rep. 2016 Apr 13;6:24368. doi: 10.1038/srep24368. Sci Rep. 2016. PMID: 27071342 Free PMC article.
-
Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties.J Biol Chem. 2022 May;298(5):101856. doi: 10.1016/j.jbc.2022.101856. Epub 2022 Mar 23. J Biol Chem. 2022. PMID: 35337800 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous